NOP16, or HBV pre-S2 trans-regulated protein 3, is revealed to be an estrogen and c-Myc target gene which is upregulated in breast cancer and associated with poor prognosis of breast cancer patients [30]. The gene discussed is MYC; the disease is breast cancer.